Literature DB >> 30378700

Natural histories of patients with Wolf-Hirschhorn syndrome derived from variable chromosomal abnormalities.

Keiko Yamamoto-Shimojima1, Masanori Kouwaki2, Yuki Kawashima3, Kazuya Itomi4, Ken Momosaki5, Shiro Ozasa5, Nobuhiko Okamoto6, Kenji Yokochi7, Toshiyuki Yamamoto1.   

Abstract

Wolf-Hirschhorn syndrome (WHS) is a subtelomeric deletion syndrome affecting the short arm of chromosome 4. The main clinical features are a typical craniofacial appearance, growth deficiency, developmental delays, and seizures. Previous genotype-phenotype correlation analyses showed some candidate regions for each clinical finding. The WHS critical region has been narrowed into the region 2 Mb from the telomere, which includes LETM1 and WHSC1; however, this region is insufficient to cause "typical WHS facial appearance". In this study, we identified 10 patients with a deletion involving 4p16.3. Five patients showed pure terminal deletions and three showed unbalanced translocations. The remaining patients showed an interstitial deletion and a suspected inverted-duplication-deletion. Among 10 patients, one patient did not show "typical WHS facial appearance" although his interstitial deletion included LETM1 and WHSC1. On the other hand, another patient exhibited "typical WHS facial appearance" although her small deletion did not include LETM1 and WHSC1. Instead, FGFRL1 was considered as the candidate for this finding. The largest deletion of 34.7 Mb was identified in a patient with the most severe phenotype of WHS.
© 2018 Japanese Teratology Society.

Entities:  

Keywords:  4p-syndrome; autism; growth failure; microarray; subtelomeric deletion

Mesh:

Year:  2018        PMID: 30378700     DOI: 10.1111/cga.12318

Source DB:  PubMed          Journal:  Congenit Anom (Kyoto)        ISSN: 0914-3505            Impact factor:   1.409


  1 in total

1.  Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement.

Authors:  Rauan Kaiyrzhanov; Sami E M Mohammed; Reza Maroofian; Ralf A Husain; Alessia Catania; Alessandra Torraco; Ahmad Alahmad; Marina Dutra-Clarke; Sabine Grønborg; Annapurna Sudarsanam; Julie Vogt; Filippo Arrigoni; Julia Baptista; Shahzad Haider; René G Feichtinger; Paolo Bernardi; Alessandra Zulian; Mirjana Gusic; Stephanie Efthymiou; Renkui Bai; Farah Bibi; Alejandro Horga; Julian A Martinez-Agosto; Amanda Lam; Andreea Manole; Diego-Perez Rodriguez; Romina Durigon; Angela Pyle; Buthaina Albash; Carlo Dionisi-Vici; David Murphy; Diego Martinelli; Enrico Bugiardini; Katrina Allis; Costanza Lamperti; Siegfried Reipert; Lotte Risom; Lucia Laugwitz; Michela Di Nottia; Robert McFarland; Laura Vilarinho; Michael Hanna; Holger Prokisch; Johannes A Mayr; Enrico Silvio Bertini; Daniele Ghezzi; Elsebet Østergaard; Saskia B Wortmann; Rosalba Carrozzo; Tobias B Haack; Robert W Taylor; Antonella Spinazzola; Karin Nowikovsky; Henry Houlden
Journal:  Am J Hum Genet       Date:  2022-09-01       Impact factor: 11.043

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.